AmCad BioMed Corporation (TPEX:4188)
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST
| Market Cap | 699.83M -27.3% |
| Revenue (ttm) | 26.16M -39.9% |
| Net Income | -55.64M |
| EPS | -0.88 |
| Shares Out | 63.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 177,280 |
| Open | 12.00 |
| Previous Close | 12.15 |
| Day's Range | 10.95 - 12.00 |
| 52-Week Range | 9.06 - 18.85 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Feb 26, 2027 |